157 related articles for article (PubMed ID: 38476086)
1. LncRNA CTBP1-AS inhibits TP63-mediated activation of S100A14 during prostate cancer progression.
Wu G; Dong Z; Dong Y; Chen Y; Zhu H; Ding D; Cui Y; Wang Y; Xu Y; Chen H
Cancer Sci; 2024 May; 115(5):1492-1504. PubMed ID: 38476086
[TBL] [Abstract][Full Text] [Related]
2. CTBP1 depletion on prostate tumors deregulates miRNA/mRNA expression and impairs cancer progression in metabolic syndrome mice.
Dalton GN; Massillo C; Scalise GD; Duca R; Porretti J; Farré PL; Gardner K; Paez A; Gueron G; De Luca P; De Siervi A
Cell Death Dis; 2019 Apr; 10(4):299. PubMed ID: 30931931
[TBL] [Abstract][Full Text] [Related]
3. The previously uncharacterized lncRNA APP promotes prostate cancer progression by acting as a competing endogenous RNA.
Shi X; Zhang W; Nian X; Lu X; Li Y; Liu F; Wang F; He B; Zhao L; Zhu Y; Ren S; Sun Y
Int J Cancer; 2020 Jan; 146(2):475-486. PubMed ID: 31107971
[TBL] [Abstract][Full Text] [Related]
4. S100A14 inhibits cell growth and epithelial-mesenchymal transition (EMT) in prostate cancer through FAT1-mediated Hippo signaling pathway.
Jiang S; Zhu Y; Chen Z; Huang Z; Liu B; Xu Y; Li Z; Lin Z; Li M
Hum Cell; 2021 Jul; 34(4):1215-1226. PubMed ID: 33890248
[TBL] [Abstract][Full Text] [Related]
5. CTBP1/CYP19A1/estradiol axis together with adipose tissue impacts over prostate cancer growth associated to metabolic syndrome.
Massillo C; Dalton GN; Porretti J; Scalise GD; Farré PL; Piccioni F; Secchiari F; Pascuali N; Clyne C; Gardner K; De Luca P; De Siervi A
Int J Cancer; 2019 Mar; 144(5):1115-1127. PubMed ID: 30152543
[TBL] [Abstract][Full Text] [Related]
6. SP1-mediated upregulation of lncRNA SNHG4 functions as a ceRNA for miR-377 to facilitate prostate cancer progression through regulation of ZIC5.
Wang ZY; Duan Y; Wang P
J Cell Physiol; 2020 Apr; 235(4):3916-3927. PubMed ID: 31608997
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of AR-regulated lncRNA TMPO-AS1 correlates with tumor progression and poor prognosis in prostate cancer.
Huang W; Su X; Yan W; Kong Z; Wang D; Huang Y; Zhai Q; Zhang X; Wu H; Li Y; Li T; Wan X
Prostate; 2018 Dec; 78(16):1248-1261. PubMed ID: 30105831
[TBL] [Abstract][Full Text] [Related]
8. Androgen-responsive long noncoding RNA CTBP1-AS promotes prostate cancer.
Takayama K; Horie-Inoue K; Katayama S; Suzuki T; Tsutsumi S; Ikeda K; Urano T; Fujimura T; Takagi K; Takahashi S; Homma Y; Ouchi Y; Aburatani H; Hayashizaki Y; Inoue S
EMBO J; 2013 Jun; 32(12):1665-80. PubMed ID: 23644382
[TBL] [Abstract][Full Text] [Related]
9. Role of transcriptional corepressor CtBP1 in prostate cancer progression.
Wang R; Asangani IA; Chakravarthi BV; Ateeq B; Lonigro RJ; Cao Q; Mani RS; Camacho DF; McGregor N; Schumann TE; Jing X; Menawat R; Tomlins SA; Zheng H; Otte AP; Mehra R; Siddiqui J; Dhanasekaran SM; Nyati MK; Pienta KJ; Palanisamy N; Kunju LP; Rubin MA; Chinnaiyan AM; Varambally S
Neoplasia; 2012 Oct; 14(10):905-14. PubMed ID: 23097625
[TBL] [Abstract][Full Text] [Related]
10. LINC01426 contributes to clear cell renal cell carcinoma progression by modulating CTBP1/miR-423-5p/FOXM1 axis via interacting with IGF2BP1.
Jiang Y; Zhang H; Li W; Yan Y; Yao X; Gu W
J Cell Physiol; 2021 Jan; 236(1):427-439. PubMed ID: 32583425
[TBL] [Abstract][Full Text] [Related]
11. S100A14 promotes progression and gemcitabine resistance in pancreatic cancer.
Zhu H; Gao W; Li X; Yu L; Luo D; Liu Y; Yu X
Pancreatology; 2021 Apr; 21(3):589-598. PubMed ID: 33579599
[TBL] [Abstract][Full Text] [Related]
12. CLCA2 epigenetic regulation by CTBP1, HDACs, ZEB1, EP300 and miR-196b-5p impacts prostate cancer cell adhesion and EMT in metabolic syndrome disease.
Porretti J; Dalton GN; Massillo C; Scalise GD; Farré PL; Elble R; Gerez EN; Accialini P; Cabanillas AM; Gardner K; De Luca P; De Siervi A
Int J Cancer; 2018 Aug; 143(4):897-906. PubMed ID: 29536528
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of long chain non-coding RNA CTBP1-AS in regulation of invasion and migration of breast cancer cells.
Cui HB; Geng CZ
J Biol Regul Homeost Agents; 2019 May-Jun,; 33(3):773-785. PubMed ID: 31165609
[TBL] [Abstract][Full Text] [Related]
14. The CtBP1-HDAC1/2-IRF1 transcriptional complex represses the expression of the long noncoding RNA GAS5 in human osteosarcoma cells.
Zhang X; Du K; Lou Z; Ding K; Zhang F; Zhu J; Chang Z
Int J Biol Sci; 2019; 15(7):1460-1471. PubMed ID: 31337976
[TBL] [Abstract][Full Text] [Related]
15. ETV5-mediated upregulation of lncRNA CTBP1-DT as a ceRNA facilitates HGSOC progression by regulating miR-188-5p/MAP3K3 axis.
Liu P; Fu R; Chen K; Zhang L; Wang S; Liang W; Zou H; Tao L; Jia W
Cell Death Dis; 2021 Dec; 12(12):1146. PubMed ID: 34887384
[TBL] [Abstract][Full Text] [Related]
16. m
Lang C; Yin C; Lin K; Li Y; Yang Q; Wu Z; Du H; Ren D; Dai Y; Peng X
Clin Transl Med; 2021 Jun; 11(6):e426. PubMed ID: 34185427
[TBL] [Abstract][Full Text] [Related]
17. Regulatory Mechanism of lncRNA CTBP1-AS2 in Nasopharyngeal Carcinoma Cell Proliferation and Apoptosis via the miR-140-5p/BMP2 Axis.
Huang B; Li Y; Deng Z; Lan G; Si Y; Zhou Q
Protein Pept Lett; 2022; 29(7):621-630. PubMed ID: 35894463
[TBL] [Abstract][Full Text] [Related]
18. Analyzing roles of small nucleolar RNA host gene 25 from clinical, molecular target and tumor formation in prostate cancer.
Liu Z; Ke S; Wang Q; Gu X; Zhai G; Shao H; He M; Guo J
Exp Cell Res; 2023 Aug; 429(2):113686. PubMed ID: 37307941
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of long non-coding RNA LOC400891 promotes tumor progression and poor prognosis in prostate cancer.
Wang J; Cheng G; Li X; Pan Y; Qin C; Yang H; Hua L; Wang Z
Tumour Biol; 2016 Jul; 37(7):9603-13. PubMed ID: 26797783
[TBL] [Abstract][Full Text] [Related]
20. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer.
Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M
J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]